Sertraline, escitalopram and tianeptine related abnormal movements but not with bupropion: a case report.
It is not scarce that patients experience various extrapyramidal symptoms (EPS) during antidepressant drug therapy. Thus, choice of an antidepressant drug in case of extrapyramidal side effects, at present, is a dilemma. Escitalopram, which is a recently marketed selective serotonin reuptake inhibitors (SSRI), has no such reputation. There is just one case reported for tianeptine that induced abnormal involuntary movements/extrapyramidal side effects. We would like to present a case that was successfully managed with bupropion which had developed EPS during 2 different SSRI (sertraline and escitalopram) and tianeptine therapy.
Ozalp
Elvan
E
Ankara Oncology Training and Research Hospital, Psychiatry Clinic, Kolej, Ankara, Turkey.
Soygur
Haldun
H
Cankurtaran
Eylem S
ES
Turhan
Levent
L
Cekic
Tuğba
T
Akarsu
Eyüp S
ES
Palaoglu
Ozden
O
Ayhan
Ismail H
IH
D000328:Adult; D016642:Bupropion / Q000009:adverse effects*; D015283:Citalopram / Q000009:adverse effects*; D018765:Dopamine Uptake Inhibitors / Q000009:adverse effects*; D020820:Dyskinesias / Q000209:etiology*; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020280:Sertraline / Q000009:adverse effects*
D016642:Bupropion; D015283:Citalopram; D018765:Dopamine Uptake Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline